As of 2025-12-30, the EV/EBITDA ratio of Willow Biosciences Inc (WLLW.TO) is
-37.60.
EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. WLLW.TO's latest enterprise value
is 107.58 mil CAD. WLLW.TO's TTM EBITDA according to its financial statements is
-2.86 mil CAD. Dividing these 2
quantities gives us the above WLLW.TO EV/EBITDA ratio.
|
Range |
Selected |
| Trailing P/E multiples |
1.5x - 2.2x |
1.8x |
| Forward P/E multiples |
2.8x - 3.1x |
3.0x |
| Fair Price |
(0.01) - 0.24 |
0.11 |
| Upside |
-104.5% - 42.1% |
-35.1% |